| | | Single nucleotide variant (5 prime UTR variant +1 more) | not provided +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not specified +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +1 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +4 more | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Fanconi anemia complementation group O +7 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Fanconi anemia complementation group O +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not specified +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | not specified +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (stop lost +2 more) | not provided +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant +2 more) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +3 more | |
| | | Single nucleotide variant (missense variant) | not specified +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Breast and/or ovarian cancer +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Breast and/or ovarian cancer +3 more | |
| | | Single nucleotide variant (synonymous variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +5 more | |
| | | Single nucleotide variant (synonymous variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Duplication (inframe_insertion) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense +1 more) | RAD51C-related disorder +6 more | GPathogenic/Likely pathogenic |
| | LOC129390903, RAD51C (H207Q) | Single nucleotide variant (missense variant +1 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (Y210*) | Single nucleotide variant (nonsense +1 more) | Hereditary breast ovarian cancer syndrome +5 more | GPathogenic/Likely pathogenic |
| | LOC129390903, RAD51C (R212H) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (R214C) | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +6 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (D215G) | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | LOC129390903, RAD51C (L219S) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (L226P) | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | LOC129390903, RAD51C (P227L) | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | LOC129390903, RAD51C (F229L) | Single nucleotide variant (missense variant +1 more) | not specified +2 more | |
| | | Indel (nonsense +1 more) | not provided | |
| | LOC129390903, RAD51C (K235N) | Single nucleotide variant (missense variant +1 more) | Breast and/or ovarian cancer +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +5 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not specified +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not specified +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +7 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not specified +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | not provided +3 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +1 more) | Fanconi anemia complementation group O +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | not provided +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | | Single nucleotide variant (splice acceptor variant) | Hereditary breast ovarian cancer syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +2 more | |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Deletion (intron variant) | not provided +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Duplication | not provided | |
| | | Deletion | not provided | |